News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
Spotlight

home
Topic
Lupin pharmaceuticals

Lupin Pharmaceuticals

Lupin

Lupin Q4FY24: Net Profit Surges by 52%, Share Price Takes a Hit

BY Outlook Business Desk

Zydus Lifesciences Gets Final USFDA Approval For Drug To Treat High Uric Acid

Lupin, Zydus Lifesciences Ink Licensing, Supply Pact For Saroglitazar Mg

BY Press Trust of India

Lupin Gets USFDA Nod For Generic Medication

Lupin Gets USFDA Nod For Generic Medication

Lupin Gets USFDA Nod To Market Generic Drug

Lupin Gets USFDA Nod To Market Generic Drug

BY Press Trust of India

Lupin Launches Covid-19 Drug Molnulup In India

Lupin Acquires Two Diabetes Drugs From Boehringer Ingelheim

BY PTI

Lupin Pharmaceuticals

Lupin Recalls Over 16,000 Bottles Of Generic Tuberculosis Drug In US After Failing Tests

BY PTI

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2024 Outlook Publishing India Pvt Ltd.

Copyright © 2024 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.